Bob
Senior Member
- Messages
- 16,455
- Location
- England (south coast)
Hi, Some seem worried about the different treatment of controls from patients. Let me draw attention to the ScienceInsider quote:
"Mikovits described how she had treated cells from two CFS patients with a chemical, 5-Azacytidine, that takes methyl groups off DNA."
The bolding is mine. The facts are only coming out slowly and too many are leaping to unsubstantiated conclusions, either for or against various points of view.
Two patients tested differently? My guess is this was a test of an idea that they weren't sure about but ran anyway. Since it was only two patients it was way too small to include as any kind of evidence in the Science paper and was quite rightly omitted in my view. If scientists had to explain everything in minute detail then they might as well be submitting video logs of everything they do. This was not a significant factor at the time of publication of the Lombardi paper.
Later on they realized this could be important, which is why I think it was mentioned in Ottawa. Since this is minor evidence it is more proper to discuss this at a conference than in a major paper.
This whole episode is a non-event blown up to something major by media coverage. If there is a problem then the investigation by Science will uncover it, and I trust them more than I do unsubstantiated accusations. Wait for their report.
The real news is that Dr. Judy Mikovits is no longer with the WPI. This has real ramifications. This includes changes made to the research capacity at the WPI and issues over research rights.
Bye
Alex
Yes I agree Alex...
Although the 5-aza issue doesn't look particularly good to me at this point, I think that we really need to understand the whole picture before we jump to any conclusions.